The history of proprotein convertase subtilisin kexin-9 inhibitors and their role in the treatment of cardiovascular disease

A consensus has formed based on epidemiological studies and clinical trials that intervention to reduce low density lipoprotein cholesterol (LDL-C) will reduce cardiovascular disease (CVD) events. This has progressively reduced the thresholds for intervention and targets for treatment. Whist statins...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eun Ji, Wierzbicki, Anthony S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Prevention and Treatment of Cardiovascular Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268157/
https://www.ncbi.nlm.nih.gov/pubmed/32537117
http://dx.doi.org/10.1177/2040622320924569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268157/
https://www.ncbi.nlm.nih.gov/pubmed/32537117
http://dx.doi.org/10.1177/2040622320924569

Ejemplares similares